Article Details

Lilly to submit obesity pill after hitting goal in third late-stage trial | BioPharma Dive

Retrieved on: 2025-08-26 17:11:21

Tags for this article:

Click the tags to see associated articles and topics

Lilly to submit obesity pill after hitting goal in third late-stage trial | BioPharma Dive. View article details on hiswai:

Excerpt

In people with diabetes and obesity, orforglipron led to weight loss near what people without diabetes experienced in prior testing.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo